focus -WSS

focus

author：hotspot 2025-09-06 03:55:28 - browse：14

Vials and packaging for Leqembi, a new Alzheimer's medication approved in the U.S., but not yet in Europe. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

LONDON — Starting Sunday, Alzheimer’s specialists will gather for a major conference in Amsterdam, convening at a time when the field, depending on which expert you ask, has some rare momentum behind it, with new therapies starting to show benefits for patients.

But despite the hard-won victories, the arrival of the new therapies presents a new set of challenges in Europe as countries plan for their possible rollouts, scientists and doctors told STAT.

Health systems will have to adapt to diagnose people earlier and monitor them for side effects associated with the treatments. If their medicines win European approval, companies will have to strike reimbursement deals in all member states, a process that often leaves some countries waiting years for new drugs to become available. The hurdles mean the therapies will likely be offered only at certain centers initially, constraining how many patients have access to them, doctors from across Europe said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： 7 more heat

WSS

HIV drugs protect against transmission, even in unprotected sex

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

HIV drugs protect against transmission, even in unprotected sex

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Texas Department of Public Safety speaks out on migrant abuse allegations

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

hotspot

focus

hotspot

Jerome Adams on the need for new antivirals for Covid

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Anesthesiologist group: stop taking Ozempic before surgery

At ASCO, AstraZeneca reports strong data for breast cancer drug

Affirmative action in medical school literally saved lives

Cord blood banking comes at a high cost to babies

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Shifting the focus from loneliness to social health

After affirmative action ruling, medical educators look to 'holistic review'

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

knowledge

Cord blood banking comes at a high cost to babies

Vir antibody drug aimed at influenza A fails in clinical trial

Letters to First Opinion on caregivers, digital health, and more

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Awakening the world to the whoosh: A patient's crusade

Intellia reports positive results for its CRISPR

leisure time

knowledge

hotspot

explore